deacetoxyvinzolidine has been researched along with trifluoperazine in 3 studies
*Trifluoperazine: A phenothiazine with actions similar to CHLORPROMAZINE. It is used as an antipsychotic and an antiemetic. [MeSH]
*Trifluoperazine: A phenothiazine with actions similar to CHLORPROMAZINE. It is used as an antipsychotic and an antiemetic. [MeSH]
| Studies (deacetoxyvinzolidine) | Trials (deacetoxyvinzolidine) | Recent Studies (post-2010) (deacetoxyvinzolidine) | Studies (trifluoperazine) | Trials (trifluoperazine) | Recent Studies (post-2010) (trifluoperazine) |
|---|---|---|---|---|---|
| 10 | 0 | 1 | 3,696 | 157 | 198 |
| Protein | Taxonomy | deacetoxyvinzolidine (IC50) | trifluoperazine (IC50) |
|---|---|---|---|
| Genome polyprotein | 0.7 | ||
| Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens (human) | 8 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Lysozyme C-1 | Rattus norvegicus (Norway rat) | 9 | |
| Beta-glucuronidase | Rattus norvegicus (Norway rat) | 7.8 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 6.75 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 6.226 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.35 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.35 | |
| Pleiotropic ABC efflux transporter of multiple drugs | Saccharomyces cerevisiae S288C | 1.4 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.35 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.016 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 6.226 | |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | 6.226 | |
| WD repeat-containing protein 48 | Homo sapiens (human) | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capuozzo, E; Crifo, C; Orosz, F; Ovádi, J; Salerno, C; Vértessy, BG | 1 |
| Böcskei, Z; Harmat, V; Náray-Szabó, G; Orosz, F; Ovádi, J; Vertessy, BG | 1 |
| Harmat, V; Hlavanda, E; Horváth, I; Nagy, A; Náray-Szabó, G; Nyitray, L; Ovádi, J; Pálfi, V; Perczel, A | 1 |
3 other study(ies) available for deacetoxyvinzolidine and trifluoperazine
| Article | Year |
|---|---|
The interaction of a new anti-tumour drug, KAR-2 with calmodulin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calcium; Calmodulin; Cattle; Circular Dichroism; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Isoenzymes; Neutrophils; Phosphofructokinase-1; Protein Binding; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Trifluoperazine; Vinblastine | 1997 |
Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies.
Topics: Animals; Binding Sites; Calmodulin; Cattle; Circular Dichroism; Crystallization; Crystallography, X-Ray; Ligands; Macromolecular Substances; Melitten; Models, Molecular; Pharmaceutical Preparations; Protein Conformation; Spectrometry, Fluorescence; Trifluoperazine; Vinblastine | 1998 |
The structure of the complex of calmodulin with KAR-2: a novel mode of binding explains the unique pharmacology of the drug.
Topics: Animals; Binding Sites; Brain; Calmodulin; Cattle; Circular Dichroism; Crystallography, X-Ray; Dopamine Antagonists; Dose-Response Relationship, Drug; Kinetics; Magnetic Resonance Spectroscopy; Models, Biological; Models, Chemical; Models, Molecular; Phosphoric Diester Hydrolases; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Structure-Activity Relationship; Surface Plasmon Resonance; Time Factors; Trifluoperazine; Vinblastine; X-Ray Diffraction | 2005 |